Neudle.com: cerebellar atrophy secondary

Differential
(Click to cross reference)

abdominal contractions

abdominal distention

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome, heralded by neurologic invol

acquired immunodeficiency syndrome, infants and children

ACTH, ectopic syndrome of

Adies pupil

adverse drug reaction

agitation

alcohol

alcohol intoxication

alcohol, blood level of

alcohol, heart involvement with

alcohol, neurologic complications with

alcoholic polyneuropathy

alcoholic withdrawal states, DT's, convulsions, etc.

alcoholism

alpha-fetoprotein

alternating rapid movement

amenorrhea

amnesia

amphiphysin antibodies

amyloid plaques

anatomy of

anemia

aneurysm, intracranial

angiography, cerebral

anti mGluR1 encephalitis

antibodies to voltage-gated calcium channels

anticonvulsants, untoward effects of

antithyroid antibodies

antiviral agents

aphasia

apraxia of eye movements

areflexia

Arnold Chiari malformation

arthralgia

ataxia

ataxia telangiectasia

auditory evoked brainstem potentials

autoantibodies

autoimmune cerebellar ataxia

autoimmune disease

autoimmune encephalopathy

autonomic dysfunction

autonomic neuropathy

axonal spheroid

basal ganglia, calcification of

brainstem, infarction of

calcification, intracranial

calcium channel dysfunction

CAR syndrome

carcinoembryonic antigen

CAT scan, disappearing lesion on

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, pelvis

catalepsy

cataracts

cataracts, congenital

cauda equina, enhancement

celiac disease, adult

central nervous system, infection of

central pontine myelinolysis

cerebellar ataxia, children

cerebellar ataxia, hereditary

cerebellar ataxia, neuropathy and vestibular areflexia syndrome

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar pontine angle tumor

cerebellar vermis

cerebellitis

cerebellitis, autoimmune

cerebellum

cerebellum, disease of

cerebral cortex

cerebral cortical atrophy

cerebral vasculature

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, enzymes in

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, prevention of

chemotherapy, CNS treatment and complications with

chromosomal abnormality

cisterna magna, enlarged

Clinical Pathologic Conference(C.P.C.)

coenzyme Q10 deficiency

cognition

collapsin response mediator protein 5 IgG

coma

compression neuropathy

confusion

consanguinity

contactin associated protein like 2 antibodies

controversies in neurology

corpus callosum, lesion of

cough

cranial nerve palsies

cranial neuropathy

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

cultured skin fibroblasts

cytosine arabinoside

deafness

degenerative diseases of CNS

dementia, frontotemporal

dementia, presenile

demyelinating disease

dentate nuclei, lesion of

depression

dermatomyositis

developmental abnormality of brain

developmental retardation

differential diagnosis

dilantin

dilantin, factors influencing metabolism of

dilantin, serum level

dilantin, toxicity

diplopia

disease modifying agents

down-beat nystagmus, primary position of gaze

DPPX

DPPX, antibodies, encephalitis

drooling

drug induced neurologic disorders

dyssynergia cerebellaris myoclonica

dystonia

echolalia

ectatic basilar artery

electrical injury of nervous system

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, focal

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, paraneoplastic

encephalopathy

enzyme, defect

eosinophilia

epidemiology of neurology

exome sequencing

extraocular muscle lesion

eye movement, disorders of

face, numbness of

facial appearance, abnormal

familial hemiplegic migraine

familial periodic ataxia

fatigue

fetal alcohol syndrome

fever

fine motor function, impaired

finger nose finger test

foam cells

foot deformity

fourth ventricle, enlargement of

Fragile-X associated tremor/ataxia-syndrome

fragile-X syndrome

fragile-X syndrome, carrier

Friedreich's ataxia

Friedreich's ataxia, late onset

frontotemporal dementia, behavioral variant

gadolinium

gait disorder

gammaglobulin therapy, intravenous

ganglionitis

gangliosidosis GM2

gastroenteritis

gastrointestinal disease, neurologic complications

gastrointestinal motility

gastroparesis

gaze palsy

gaze palsy, horizontal

gaze palsy, supranuclear

gene

gene mutation

genetic linkage

genetic neurologic disorders

genetic testing

Gerstmann-Straussler-Scheinker disease

gliadin antibodies

globus pallidus, lesion of

glutamic acid decarboxylase, antibody

growth hormone deficiency

growth retardation

Guillain Barre syndrome

gynecomastia

Hallervorden Spatz disease

hearing loss, bilateral

heatstroke

heel-knee-shin test

hemianopia

hemianopia, transient

hemifacial spasm

hemiparesis

hemiplegia

hepatic encephalopathy

hepatosplenomegaly

heralding manifestation

highly active antiretroviral therapy

histochemistry

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

hot cross bun sign

human immunodeficiency virus type 1

human T-lymphotropic virus type II(HTLV-II)

hydrocephalus

hydroxytryptophan L-5(L-5 HTP)

hyperactivity

hypercalcemia

hyperesthesia

hyperpigmentation of skin

hypogonadism, hypogonadotropic

hypokalemia

hypokalemic alkalosis

hypometric saccades

hypomyelination

hyponatremia

hypothalamus, damage to

hypothyroidism

hypotonia

imbalance

immune reconstitution inflammatory syndrome

immunocompetent

immunodeficiency

immunologic disease

immunology and the nervous system

intellectual deterioration

internal capsule

internuclear ophthalmoplegia

internuclear ophthalmoplegia, bilateral

intestinal biopsy

intestinal pseudoobstruction

irritability

isoniazid

Jakob-Creutzfeldt disease

jaundice

JC virus

Korsakoff's psychosis

lactic acidemia

laughing, pathologic

leg numbness

leg weakness, bilateral

Leigh's disease

leucine rich glioma inactivated 1 antibodies

level of consciousness, decreased

limbic encephalitis

lipid storage disorder of CNS

lymphadenopathy

lymphoma

lymphoma involving CNS

lysosomal storage disease

malabsorption

malabsorption syndrome

malformation, CNS, congenital

malignancy screen

malignancy, occult

Marchiafava-Bignami disease

Marinesco-Sjogren syndrome

mediastinum, mass of

MELAS syndrome

memory, defect of recent

memory, impairment of

meningitis

mental retardation

mental status, abnormal

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebellar peduncle, lesion, bilateral

mitochondrial disease

mitochondrial encephalomyopathy

mitochondrial recessive ataxic syndrome

MNGIE syndrome

monoclonal antibodies

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

mortality

motor neuron disease

movement disorder

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, abnormal, seizure causing

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, high signal foci on

multiple system atrophy

muscle biopsy

muscle pain

muscle weakness

muscle weakness, proximal

mutism

myasthenia gravis, paraneoplastic

myelopathy, carcinomatous

myelopathy, necrotizing

myoclonus, stimulus sensitive

myoclonus-ataxia syndrome

myopathy

myopathy, alcoholic

myopathy, mitochondrial

myopia

Native Americans

nausea and vomiting

neoplasm, hormone producing

neoplasm, hormone producing, ectopic

nephrotic syndrome

nerve conduction studies

neuroaxonal dystrophy

neuroaxonal dystrophy, infantile

neuroaxonal dystrophy, juvenile

neurocutaneous disease

neuroendocrinology

neuroleptic malignant syndrome

neurologic complications

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic signs

neuromuscular junction

neuronal cell surface antigen

neuronal ceroid-lipofuscinosis

neuronopathy

neuronopathy, sensory

neuropathy, paraneoplastic

neuropathy, peripheral

next-generation sequencing

Niemann-Pick disease

NMDA antagonists

NMDA receptors

nutritional deficiency

nystagmus

nystagmus, gaze-evoked

nystagmus, primary position of gaze

nystagmus, rotary

nystagmus, upbeating on upgaze

nystagmus, vertical

occipital lobe, infarction

occipital lobe, lesion of

ocular dysmetria

ocular flutter

ocular motility, disorders of

old age, neurology of

onconeural antibodies

ophthalmoplegia

opsoclonus

opsoclonus-myoclonus syndrome

optic atrophy

optic neuropathy

optic neuropathy, nutritional

paraneoplastic brainstem encephalitis

paraneoplastic cerebellar degeneration

parietal lobe, lesion of

Parkinson disease

Parkinsonism syndrome

parotid gland neoplasm

pathology

pellagra

pelvic mass

peripheral nerve, lesion of

pes cavus

photosensitivity, skin

pigmentary retinopathy

pitfalls

pituitary, lesion of

plasmapheresis

pleocytosis of cerebrospinal fluid

POLG1 gene

polymerase chain reaction

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, atrophy

pons, infarction of

pons, lesion of

positional head-hanging test

posterior fossa, lesion of

posterior inferior cerebellar artery syndrome

prion disease

progeria

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive pallidum atrophy

psychiatric problems in neurologic disorders

psychomotor retardation

psychosis

ptosis

pupil, abnormality in neurologic disorders

pupil, tonic

Purkinje cell

pursuit eye movements, abnormal

pyramidal tract dysfunction

quadriplegia

radiation hypersensitivity

ragged-red fibers

Ramsay Hunt syndrome

rapidly progressing neurologic illness

rash

reading disorder, acquired

Red flags

reflex, brainstem

remission

remote effect of cancer on the nervous system

renal failure

respiratory depression

reticulum cell sarcoma

reversible splenial lesion syndrome

saccadic eye movements, abnormal

salivation, excessive

screening

sedimentation rate, elevated

seizure

seizure, children

seizure, withdrawal

sensorineural hearing loss

Sjogren's syndrome, neurologic manifestations of

skin, biopsy

skin, lesions in neurologic disorders

solvent

spasticity

speech disorder

speech disorder, non aphasic

spinal cord, injury of

spinal cord, lesion of

spinal muscular atrophy

spinocerebellar ataxia

spinocerebellar ataxia type 1

spinocerebellar ataxia type 10

spinocerebellar ataxia type 2

spinocerebellar ataxia type 5

spinocerebellar ataxia type 6

spinocerebellar ataxia type 7

spinocerebellar ataxia type 8

spinocerebellar degeneration

splenium of corpus callosum

splenomegaly

staphylococcal protein A column therapy

subarachnoid hemorrhage

syphilis, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

thiamine

thyroiditis

titubation

transglutaminase antibodies

transient ischemic attack

treatment of neurologic disorder

trinucleotide repeats

ubiquitination

urinary gonadotropin

vertebral-basilar insufficiency

vibratory sensation, abnormal

viral infection

viral infection, CNS

viral infection, CNS, treatment of

vision, failure of in childhood

visual evoked response

visual impairment

visual loss

vitiligo

voice, abnormality of

walking frame

walking, difficulty with

weakness

weakness, generalized

weakness, progressive

weaning from respirator, failure to

weight loss

Wernicke's encephalopathy

Western immunoblot test

wheelchair

Whipple's disease

white matter disease

whole genome sequencing

Showing articles 1550 to 1600 of 4121 << Previous Next >>

Interferon Beta-1a for Brain Tissue Loss in Patients at Presentation with Syndromes Suggestive of Multiple Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:1489-1496,1463, Filippi,M.,et al, 2004

Progressive Posterior Cortical Dysfunction
Neurol 63:1175-1180, Renner,J.A.,et al, 2004

Clinical, Genetic, and Neuropathologic Characteristics of Posterior Cortical Atrophy
Neurol 63:1168-1174, Tang-Wai,D.F.,et al, 2004

PROTECT A Coordinated Stroke Treatment Program to Prevent Recurrent Thromboembolic Events
Neurol 63:1217-1222, Ovbiagele,B.,et al, 2004

Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis: Randomised Placebo-Controlled Trial
Lancet 364:1149-1156, Hommes,O.R.,et al, 2004

The MATCH Study Results in the Context of Secondary Stroke Prevention
Stroke 35:2609, Fisher,M. &Davalos,A., 2004

Thoughts Evoked by MATCH and Other Trials
Stroke 35:2604-2605, Caplan,L.R., 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1779-1787,1768, Kappos,L.,et al, 2004

Interferon beta-1b in Secondary Progressive MS
Neurol 63:1788-1795,1768, The North American Study Group on Interferon beta-, 2004

A 24-Year Follow-Up of Body Mass Index and Cerebral Atrophy
Neurol 63:1876-1881, Gustafson,D.,et al, 2004

In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up
Stroke 35:2879-2883, Ovbiagele,B.,et al, 2004

Statins in Stroke Prevention and Carotid Artherosclerosis, Systematic Review and Up-to-Date Meta-Analysis
Stroke 35:2902-2909, Amarenco,P.,et al, 2004

Correlation Between Antemortem Magnetic Resonance Imaging Findings and Pathologically Confirmed Corticobasal Degeneration
Arch Neurol 61:1881-1884, Josephs,K.A.,et al, 2004

Idiopathic Hypertrophic Pachymeningitis
Neurol 62:686-694, Kupersmith,M.J.,et al, 2004

Plasmapheresis Improves Outcome in Postinfectious Cerebellitis Induced by Epsteiin-Barr Virus
Neurol 62:1443, Schmahmann,J.D., 2004

Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004

Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004

A Paralysed Thumb
Lancet 363:1364, Sudo,K.,et al, 2004

Charcot-Marie-Tooth Disease:Extensive Cranial Nerve Involvement on CT and MR Imaging
AJNR 25:494-497, Aho,T.R.,et al, 2004

Endarterectomy for Symptomatic Carotid Stenosis in Relation to Clinical Subgroups and Timing of Surgery
Lancet 363:915-924, Rothwell,P.M.,et al, 2004

Effects of Cholesterol-lowering with Simvastatin on Stroke and Other Major Vascular Events in 20 536 People with Cerebrovascular Disease or Other High-Risk Conditions
Lancet 363:757-767, Heart Protection Study Collaborative Group, 2004

The Parkinsonian Phenotype of Spinocerebellar Ataxia Type 2
Arch Neurol 61:35-38, Lu,C.,et al, 2004

The Effect of Spinal Cord Stimulation in Patients with Chronic Reflex Sympathetic Dystrophy: Two Years' Follow-up of the Randomized Controlled Trial
Ann Neurol 55:13-18,5, Kemler,M.A.,et al, 2004

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004

Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
JAMA 291:460-469, Jacquemont,S.,et al, 2004

Imaging Cerebral Atrophy:Normal Ageing to Alzheimer's Disease
Lancet 363:392-394, Fox,N.C.&Schott,J.M., 2004

Benefit of Clopidogrel Over Aspirin is Amplified in Patients with a History of Ischemic Events
Stroke 35:528-532, Ringleb,P.A.,et al, 2004

Population Based Study of Early Risk of Stroke after Transient Ischaemic Attack or Minor Stroke:Implications for Public Education and Organisation of Services
BMJ 328:326-328,297, Coull,A.J.,et al, 2004

Blood Pressure and Stroke
Stroke 35:776-785, Lawes,C.M.M.,et al, 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Early Diagnosis of Central Pontine Myelinolysis with Diffusion-Weighted Imaging
AJNR 25:210-213, Ruzek,K.A.,et al, 2004

The Clinical Significance of Diffusion-Weighted MR Imaging in Infratentorial Strokes
Neurol 62:574-580, Englelter,S.T.,et al, 2004

Comparison of Different MRI Brain Atrophy Rate Measures with Clinical Disease Progression in AD
Neurol 62:591-600, Jack, Jr.,C.R.,et al, 2004

Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004

Clinical Spectrum of Episodic Ataxia Type 2
Neurol 62:17-22, Jen,J.,et al, 2004

Infantile Bilateral Striatal Necrosis Maps to Chromosome 19q
Neurol 62:87-90, Basel-Vanagaite,L.,et al, 2004

Neuro-Ophthalmic Findings in the Visual Variant of Alzheimers Disease
Ophthalmology 111:376-381, Lee,A.G. &Martin,C.O., 2004

Morning Glory Sign: A Particular MR Finding in Progressive Supranuclear Palsy
Magn Reson Med Sci 3:125-132, Adachi, M., et al, 2004

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003

Telemedicine in Emergency Evaluation of Acute Stroke
Stroke 34:2842-2846, Handschu,R.,et al, 2003

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

The CNS Phenotype of X-Linked Charcot-Marie-Tooth Disease
Neurol 61:1475-1478, Taylor,R.A.,et al, 2003

Clinicopath Conf., Meningencephalitis and Sepsis Due to Neisseria Meningitidis Infection
NEJM 349:2341-2349, Case 38-2003, 2003

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

Dementia with Lewy Bodies
Lancet 362:1689-1690, Wilcock,G.K., 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

Showing articles 1550 to 1600 of 4121 << Previous Next >>